fda stopping semaglutide Compound versions of GLP-1 drugs for weight loss halted by New Novo Nordisk initiatives support
Description
Accessed 25 Nov 2024
On this Whats Up Doc episode, Dr
doi: 10.1016/j.cmet.2023.07.010 75 WillardFSDourosJDGabeMBShowalterADWainscottDBSuterTMet al
Testosterone Therapy for Andropause: Benefits and Risks As men age, their testosterone levels naturally decline, with an average decrease of about 1% annually after age 40
Individuals with a BMI of 30 kg/m or higher may qualify directly, while those with a BMI of 27 kg/m or higher may be eligible if they have weight-related health conditions like hypertension, type 2 diabetes , elevated cholesterol, or obstructive sleep apnea
